ISSN: 1300-0292
İndekslendiği Dizinler: SCIENCE CITATION INDEX EXPANDED
CINAHL, Index Copernicus,
Chemical Abstracts (CA),
Excerpta Medica / EMBASE
Dil: Türkçe, İngilizce
İçerik: Orijinal Araştırma, Derleme, Editöre Mektup, Olgu Sunumu, Tıp Eğitimi, Tıbbi Kitap İncelemeleri
|
|
|
|
Thrombopoeietin
Yavuz BAYKAL*, Gülsüm ÖZET**, Ahmet ÖZET*
* Doç.Dr.,GATA İç Hastalıkları BD,
** Dr.,Ankara Numune Hastanesi, ANKARA
With the discovery of thrombopoietin, the last of the lineage specific cytokines has been idenfied and brought and into the clinical area. Thrombopoietin promises to be an exciting toll with which to understand megakayocyte and trombosit biology. Certainly, thombopoietin will increase the trombosit count in most clinical situations and is expected to have little associated toxicity. It may be highly effective in chronic thrombocytopenic disorders, its utility in oncology is unclear given the relative rarity of trombocytopenic bleeding in most current protcols and the ready avaibility of trombosit concentrates. The many studies that will appear over next several years should help define the role thrombopoeietin in oncology.
Keywords: Trombopoeietin
Turkiye Klinikleri J Med Sci 1998, 18:292-298
|
|
|
|
|
